TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22316565

Group type: EXPERIMENTAL
Intervention: Psychoeducation program (2 hours/week for six weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard care and information (control group)
Number of subjects: 71
Study: 20462392

Group type: EXPERIMENTAL
Intervention: 10 mg montelukast (MK)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low PM PL
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low PM MK
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High PM MK
Number of subjects: 10
Study: 18615295

Group type: EXPERIMENTAL
Intervention: Exam room staffing (n = 120)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Conference room staffing (n = 134)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Exam room staffing
Number of subjects: 254
Study: 16042665

Group type: EXPERIMENTAL
Intervention: GPI 5693 1125 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPI 5693 300 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPI 5693 750 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPI 5693 with food intake (750 mg and 1125 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPI 5693 300 mg, 750 mg, and 1125 mg
Number of subjects: 0
Study: 12074820

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Burch colposuspension (BC)
Number of subjects: 71
Study: 10467215

Group type: EXPERIMENTAL
Intervention: Antihypertensive medication (specifics not provided)
Number of subjects: 0
Study: 7762265

Group type: EXPERIMENTAL
Intervention: DPT and PRP-T vaccines mixed in one syringe (n = 183)
Number of subjects: 367

Group type: COMPARATOR
Intervention: DPT and PRP-T vaccines administered separately in opposite limbs (n = 184)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Both treatment groups (combined and separate injections)
Number of subjects: 367
Study: 2281031

Group type: EXPERIMENTAL
Intervention: 75 mg of a diclofenac sodium aqueous buffered solution
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 75 mg Voltaren EC tablet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 100 mg Voltaren slow-release (SR) tablet
Number of subjects: 8

Group type: COMPARATOR
Intervention: HC alone
Number of subjects: 8
Study: 342182

Group type: EXPERIMENTAL
Intervention: Non-blind examination
Number of subjects: 175

Group type: COMPARATOR
Intervention: Blind examination
Number of subjects: 175
Study: 30917258

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus Anastrozole
Number of subjects: 694

Group type: COMPARATOR
Intervention: Anastrozole alone
Number of subjects: 694
Study: 28277355

Group type: EXPERIMENTAL
Intervention: Liberal postoperative activity recommendations (resume at own pace, no restrictions on lifting or high-impact activities)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Restricted postoperative activity recommendations (avoid heavy lifting or strenuous exercise for 3 months)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Liberal postoperative activity recommendations
Number of subjects: 95

Group type: COMPARATOR
Intervention: Restricted postoperative activity recommendations
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups (Liberal and Restricted)
Number of subjects: 95
Study: 26028546

Group type: COMPARATOR
Intervention: Placebo (placebo transdermal patches)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: APICS model
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: APICS
Number of subjects: 151
Study: 23928102

Group type: EXPERIMENTAL
Intervention: tDCS priming (anodal, cathodal) followed by low-frequency rTMS (active)
Number of subjects: 0

Group type: COMPARATOR
Intervention: tDCS priming (anodal, cathodal) followed by low-frequency rTMS (sham)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (active)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-frequency rTMS (sham)
Number of subjects: 0
Study: 22262325

Group type: EXPERIMENTAL
Intervention: Bipolar diathermy
Number of subjects: 341

Group type: COMPARATOR
Intervention: Conventional surgery (dorsal slit)
Number of subjects: 341
Study: 19577069

Group type: EXPERIMENTAL
Intervention: PAS-Port device
Number of subjects: 220

Group type: COMPARATOR
Intervention: Hand-sewn anastomosis
Number of subjects: 220
Study: 17532804

Group type: EXPERIMENTAL
Intervention: Negative mood state
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Positive mood state
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Neutral mood state
Number of subjects: 43
Study: 15145965

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg oral dose
Number of subjects: 27
Study: 11394596

Group type: EXPERIMENTAL
Intervention: Ice applied for 2 hours immediately after surgery
Number of subjects: 17

Group type: COMPARATOR
Intervention: No ice applied for the 1st hour, then ice applied for the 2nd hour
Number of subjects: 17
Study: 9588639

Group type: EXPERIMENTAL
Intervention: Oral desmopressin (DDAVP) 400 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 7976440

Group type: EXPERIMENTAL
Intervention: Religious psychotherapy in addition to supportive psychotherapy and anxiolytic drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive psychotherapy and anxiolytic drugs only
Number of subjects: 0
Study: 2730512

Group type: EXPERIMENTAL
Intervention: Interaction with Sexpert (experimental group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (questionnaire on sexual functioning)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (non-sex related computer program)
Number of subjects: 32
Study: 792738

Group type: EXPERIMENTAL
Intervention: Parsalmide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 30
Study: 29724155

Group type: EXPERIMENTAL
Intervention: Nerve Growth Factor (NGF) treatment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2
Study: 28363001

Group type: EXPERIMENTAL
Intervention: Everolimus treatment
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 244
Study: 26185263

Group type: EXPERIMENTAL
Intervention: High dose isotonic sodium bicarbonate (target 2.0 mEq/kg)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Sodium chloride (control)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: CIAKI
Number of subjects: 391
Study: 24382344

Group type: EXPERIMENTAL
Intervention: Hand washing intervention with free soap provision
Number of subjects: 847
Study: 21670699

Group type: EXPERIMENTAL
Intervention: Risk-reducing bilateral salpingo-oophorectomy (RRSO)
Number of subjects: 111
Study: 19843798

Group type: EXPERIMENTAL
Intervention: IV pentazocine 15 mg
Number of subjects: 208

Group type: COMPARATOR
Intervention: IV ondansetron 4 mg
Number of subjects: 208
Study: 17374663

Group type: EXPERIMENTAL
Intervention: 0.7 g DHA/d as a purified algal derived triacylglycerol (1.5 g/d)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (1.5 g olive oil/d)
Number of subjects: 38
Study: 15066683

Group type: EXPERIMENTAL
Intervention: Statin treatment at baseline
Number of subjects: 3806

Group type: EXPERIMENTAL
Intervention: Statin treatment after 2 years of cumulative treatment
Number of subjects: 3806
Study: 11701432

Group type: EXPERIMENTAL
Intervention: Folate deficiency
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vitamin B(6) deficiency
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 14
Study: 9399278

Group type: EXPERIMENTAL
Intervention: Repetitive practice of flexion‐extension movements of the affected elbow (800 repeated elbow movements in a maximal predetermined amplitude of 80 degrees, provided in 8 equal sessions every other day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional physical therapy for the paretic upper extremity (10 min. of therapy at similar time intervals)
Number of subjects: 27
Study: 8178915

Group type: EXPERIMENTAL
Intervention: Casting for 1 month followed by traditional therapy for 1 month
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional therapy for 1 month followed by casting for 1 month
Number of subjects: 15
Study: 3295362

Group type: EXPERIMENTAL
Intervention: Intravenous amino acid infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low sodium diet (20 mEq/day) for three days before amino acid infusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril pretreatment in subjects on low sodium diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin in volunteers with normal sodium intake
Number of subjects: 0
Study: 29391383

Group type: EXPERIMENTAL
Intervention: 12-week lifestyle intervention (one face-to-face counselling session, four telephone consultations, web-based support, personalized diet and physical activity program)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 12-week lifestyle intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (lifestyle booklet)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study: 27007583

Group type: EXPERIMENTAL
Intervention: Methadone Maintenance Therapy (MMT)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Buprenorphine Maintenance Therapy (BMT)
Number of subjects: 1000
Study: 25663469

Group type: EXPERIMENTAL
Intervention: Doxylamine succinate-pyridoxine HCl
Number of subjects: 160

Group type: COMPARATOR
Intervention: Pyridoxine
Number of subjects: 160
Study: 23077146

Group type: EXPERIMENTAL
Intervention: group OKF (n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: group OKS (n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: group OKU (n = 20)
Number of subjects: 60
Study: 20679179

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg/day for 5 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sitagliptin with 0 mg enalapril
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sitagliptin with 5 mg enalapril
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sitagliptin with 10 mg enalapril
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mg enalapril during sitagliptin
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0 mg or 5 mg enalapril
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 24
Study: 18709692

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day for 4 months
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 17217690

Group type: EXPERIMENTAL
Intervention: sPLA2 in CHD patients
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: IL-8 in CHD patients
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: LPA in CHD patients
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: sPLA2 in ACS vs SCHD
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: IL-8 in ACS vs SCHD
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Correlation of sPLA2 with hs-CRP, IL-8, and LPA
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Risk factor for CHD
Number of subjects: 262
Study: 14674497

Group type: EXPERIMENTAL
Intervention: Phosphoric acid treatment with Prime & Bond NT on enamel surfaces treated with 27-microm air-particle abrasion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Phosphoric acid treatment with Prime & Bond NT on enamel surfaces not treated with air-particle abrasion (control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Air-particle abraded surfaces (27-microm and 50-microm)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NRC with or without phosphoric acid
Number of subjects: 12
Study: 15553310

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 22099

Group type: EXPERIMENTAL
Intervention: Controlled blood pressure
Number of subjects: 22099

Group type: COMPARATOR
Intervention: Caucasian patients
Number of subjects: 22099

Group type: COMPARATOR
Intervention: Hispanic patients
Number of subjects: 22099

Group type: COMPARATOR
Intervention: Black patients
Number of subjects: 22099
Study: 10197675

Group type: EXPERIMENTAL
Intervention: Closure of the pericardium
Number of subjects: 42

Group type: COMPARATOR
Intervention: Open pericardium
Number of subjects: 42
Study: 7767525

Group type: EXPERIMENTAL
Intervention: Theophylline (300 mg twice a day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2191443

Group type: EXPERIMENTAL
Intervention: 100 mg/d oral fluconazole
Number of subjects: 13

Group type: COMPARATOR
Intervention: 400 mg/d ketoconazole
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: IV fluconazole 100 to 300 mg/d
Number of subjects: 13
Study: 637295

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 8
Study: 31381020

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 (2400 IU/d; N = 315)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Standard dose vitamin D3 (400 IU/d; N = 308)
Number of subjects: 588
Study: 28087684

Group type: EXPERIMENTAL
Intervention: Single Median Price
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Paired Internal/External Median Prices
Number of subjects: 506

Group type: COMPARATOR
Intervention: Control
Number of subjects: 506
Study: 26400188

Group type: EXPERIMENTAL
Intervention: Berberine hydrochloride 400 mg, delivered twice daily for 8 weeks
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Berberine hydrochloride
Number of subjects: 196
Study: 23706111

Group type: EXPERIMENTAL
Intervention: Guaranà 350 mg × 3 daily just after breakfast for 5 consecutive days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 22104027

Group type: EXPERIMENTAL
Intervention: Lockable safe storage container for agrochemicals
Number of subjects: 44000

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44000
Study: 19583072

Group type: EXPERIMENTAL
Intervention: WHO Analgesic Ladder
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: WHO step 3
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: NSAID only
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Adjuvant treatment
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination of NSAID and adjuvant treatment
Number of subjects: 84
Study: 17100362

Group type: EXPERIMENTAL
Intervention: Solihull Approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard health visitor practice
Number of subjects: 0
Study: 15113724

Group type: EXPERIMENTAL
Intervention: Low-energy preload (12.55 kJ)
Number of subjects: 32

Group type: COMPARATOR
Intervention: High-energy preload (627.60 kJ)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Compensation ability
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Total energy and macronutrient intake among siblings
Number of subjects: 32
Study: 11444999

Group type: EXPERIMENTAL
Intervention: Methionine (100 mg/Kg) plus vitamin C (2 g orally)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Methionine (100 mg/Kg) plus placebo tablets
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo drink plus placebo tablets
Number of subjects: 10
Study: 9226389

Group type: EXPERIMENTAL
Intervention: 0.1% delmopinol mouthrinse
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 0.2% delmopinol mouthrinse
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 7970045

Group type: EXPERIMENTAL
Intervention: 6% neostigmine (1 puff = 5.4 mg), 2 puffs per nostril, repeated every 4 hours up to 6 puffs/day for 4 days or until canalization of feces and gas was achieved.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo, 2 puffs per nostril, repeated every 4 hours up to 6 puffs/day for 4 days or until canalization of feces and gas was achieved.
Number of subjects: 40
Study: 29807806

Group type: EXPERIMENTAL
Intervention: Pill counts
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Refill records
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Clinician rating
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Drug Attitude Inventory (DAI)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Brief Adherence Rating Scale (BARS)
Number of subjects: 278
Study: 27829501

Group type: EXPERIMENTAL
Intervention: Mobilization with movement (MWM) technique
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham technique
Number of subjects: 27
Study: 25139728

Group type: COMPARATOR
Intervention: Multi-component intervention including health screenings, mobile food bus, walking groups, cooking demonstrations, and a social media campaign facilitated by community health workers.
Number of subjects: 211

Group type: COMPARATOR
Intervention: Assessment-only control group.
Number of subjects: 211
Study: 23942627

Group type: EXPERIMENTAL
Intervention: Surfactant guided by lamellar body counts (LBC)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Increasing need for oxygen (control group)
Number of subjects: 380
Study: 19890639

Group type: EXPERIMENTAL
Intervention: Group 1 (prospective ECG-triggering, 100 kV, 330 mAs)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Group 2 (retrospectively gated 'MinDose' sequence, 100 kV, 330 mAs)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Group 3 (standard spiral sequence, 120 kV, 400 mAs)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Group 1 (low-dose)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Group 2 (low-dose)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Group 3 (standard)
Number of subjects: 176
Study: 18673555

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone therapy (HT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16823406

Group type: EXPERIMENTAL
Intervention: Food allergen avoidance diet
Number of subjects: 38
Study: 12925515

Group type: EXPERIMENTAL
Intervention: Biased-coin treatment allocation rules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chi-squared approximation
Number of subjects: 0
Study: 11010943

Group type: EXPERIMENTAL
Intervention: Moderately folate-depleted diet (118 microg folate/d) for 7 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Folate repletion with 200 or 415 microg/d for 7 weeks
Number of subjects: 33
Study: 8856091

Group type: EXPERIMENTAL
Intervention: IFN-alpha 3 x 10(6) i.u. s.c. t.i.w. (group I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternating monthly cycles of IFN-alpha and chemotherapy (group II)
Number of subjects: 0
Study: 1622852

Group type: EXPERIMENTAL
Intervention: ARGIMESNA p.o., 20% of IFO dose every 2 h x 4
Number of subjects: 78

Group type: COMPARATOR
Intervention: MESNA p.o., 40% of IFO dose every 4 h x 2
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both ARGIMESNA and MESNA
Number of subjects: 78

Group type: COMPARATOR
Intervention: MESNA i.v. (added in some cases)
Number of subjects: 78
Study: 6481661

Group type: EXPERIMENTAL
Intervention: Inhaling quickly and exhaling slowly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breathing manipulations (inhaling slowly and exhaling quickly, equal time inhaling and exhaling)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distraction control condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 0
Study: 31342780

Group type: EXPERIMENTAL
Intervention: Gradual attention training (20 minutes a day, six days/week, for five weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (language treatment 20 minutes a day, six days/week, for five weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gradual attention training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 30090697

Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27624513

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention model with cognitive-behavioral therapy, care management, and psychopharmacological consultation.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 49
Study: 26842203

Group type: EXPERIMENTAL
Intervention: TMX/GOS (Tamoxifen 20 mg/day for 5 years plus Goserelin 3.6 mg injection per month for 2 years)
Number of subjects: 101

Group type: COMPARATOR
Intervention: TMX (Tamoxifen 20 mg/day for 5 years)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: TMX/GOS
Number of subjects: 101

Group type: COMPARATOR
Intervention: TMX
Number of subjects: 101
Study: 22677304

Group type: EXPERIMENTAL
Intervention: Topical preparations (0.1% tretinoin, 0.1% adapalene, 5% dapsone, 1% clindamycin, benzoyl peroxide with adapalene or clindamycin, clindamycin-tretinoin combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide preparations (2 for 2.5%, 3 for 5.0%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (placebo) for benzoyl peroxide preparations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overall vehicle contribution toward drug effect
Number of subjects: 0
Study: 20406218

Group type: EXPERIMENTAL
Intervention: PF-00821385 (0.5-120 mg kg(‐1))
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PF-00821385 (administered to 24 volunteers)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 24
Study: 19089199

Group type: EXPERIMENTAL
Intervention: Phosphoric acid 37%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: iBond
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 20
Study: 16278521

Group type: EXPERIMENTAL
Intervention: Amlodipine besylate/benazepril HCl 5/20 mg combination therapy
Number of subjects: 443

Group type: COMPARATOR
Intervention: Amlodipine besylate 5 mg
Number of subjects: 443

Group type: COMPARATOR
Intervention: Benazepril HCl 20 mg
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 443
Study: 12403667

Group type: EXPERIMENTAL
Intervention: POTS (n=16)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: NCS (n=20)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Healthy volunteers (n=52)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Age-matched healthy women (n=11)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: POTS and NCS
Number of subjects: 52